Causes of death and mortality risk factors

Nephrology Dialysis Transplantation

Volumn 19, Issue SUPPL. 3, 2004, Pages

  Alonso, Angel ^a   Oliver, Juan ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

Chronic allograft nephropathy; Kidney transplant; Patient survival; Post transplant mortality risk; Transplant deaths

Indexed keywords

AZATHIOPRINE; CREATININE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGE; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC LIVER DISEASE; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; INFECTION; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEOPLASM; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SEX DIFFERENCE; SPAIN; SURVIVAL TIME;

ADULT; CAUSE OF DEATH; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; RISK FACTORS; TIME FACTORS;

EID: 3242709636     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh1007     Document Type: Article

References (16)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, Mc Intosh M, Stablein D. Improved graft survival after renal transplantation in the United States. N Engl J Med 2000; 342: 605-612
2. Wolfe RA, Ashby UB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730
3. Gjertson DW. The role of death in kidney graft failure. Clin Transplant 1998; 399-411
4. Ojo AO, Hanson JA, Wolfe RA, Leichman L, Agodoa LY, Port FK. Long-term survival in kidney recipients with graft function. Kidney Int 2000; 57: 307-313
5. Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B. Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol 2001; 12: 1293-1296
6. Schaubel DE, Jeffery JR, Mao Y, Semenciw R, Yeates K, Fenton SS. Trends in mortality and graft failure for renal transplant patients. C M A J 2002; 167: 137-142
7. García-López FJ, Robles R, Gentil et al. Comparación de la incidencia, prevalencia, modalidades de tratamiento y mortalidad en pacientes con tratamiento renal sustitutivo en cinco comunidades autónomas españolas en el período 1991-1996. Nefrología 1999; 19: 443-459
8. Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291-1295
9. Roodnat JI, Mulder PG, Rischen-Vos J et al. Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation 2001; 72: 438-444
10. Cosio FG, Pesavento TE, Pelletier RP et al. Patient survival after renal transplantation. III: The effects of statins. Am J Kidney Dis 2002; 40: 638-643
11. Cosio FG, Falkenhain ME, Pesavento TE et al. Patient survival after renal transplantation. II. The impact smoking. Clin Transplant 1999; 13: 336-341
12. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal outcome a significant independent risk factor for graft failure and patient death. Transplantation 2002; 15: 70-74
13. EBPG Expert Group on Renal Transplantation European Best Practice Guidelines for Renal Transplantation. Section IV: Cancer Risk after Transplantation. IV.6. Commentary. Nephrol Dial Transplant 2002; 17 [Suppl 4]: 31-36
14. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transplant 1998; 147-158
15. Morales JM, Campistol JM. Transplantation in the patient with hepatitis C. J Am Soc Nephrol 2000; 11: 1343-1353
16. Meier-Kriesche HU, Ojo AO, Hanson JA, Kaplan B. Hepatitis C antibody status and outcome in renal transplant recipients. Transplantation 2001; 72: 241-244